Document Detail


The influence of gemfibrozil on malondialdehyde level and paraoxonase 1 activity in wistar and fisher rats.
MedLine Citation:
PMID:  21223511     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
There are diverse experimental data about the influence of gemfibrozil (GEM) on the production of hydrogen peroxide (H(2)O(2)) and antioxidant enzymes. We investigated the influence of GEM treatment on the production of malondialdehyde (MDA) level in tissues of normolipidaemic Wistar and Fisher rats which is an index of lipid peroxidation. Because serum paraoxonase 1 (PON1) is an important enzyme with specific protective function on metabolism of lipid peroxides, we examined the influence of GEM on PON1 activity in liver and serum. MDA level and enzyme activities were also determined 10 days after withdrawal of GEM treatment. The significantly increased levels of MDA in liver, kidney and heart of both rat strains were obtained after 3 weeks of GEM treatment. We propose two possibilities for the increase of MDA levels caused by GEM, induction of peroxisome proliferation and activities of enzymes that participated in occurrence of H(2)O(2) and possible reduction of enzyme activities including in H(2)O(2) metabolism. Ten days after withdrawal of GEM treatment, MDA levels in all tissue levels of both rat strains were less in comparison with GEM treatment. GEM caused a significant drop of PON1 activity in serum and liver of Fisher rats, and in liver of Wistar rats. We suggest that GEM, through induction of lipid peroxidation, caused the damage of hepatocytes with consequent reduction of PON1 synthesis. The increase in PON1 activity in serum and tissues of both rat strains 10 days after withdrawal of GEM treatment shows the fast recovery of enzyme synthesis.
Authors:
Marija Macan; Macan Marija; Paško Konjevoda; Konjevoda Paško; Jasna Lovric; Lovrić Jasna; Marijan Koprivanac; Koprivanac Marijan; Marta Kelava; Kelava Marta; Nada Vrkic; Vrkić Nada; Vlasta Bradamante; Bradamante Vlasta
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2011-02-24
Journal Detail:
Title:  Basic & clinical pharmacology & toxicology     Volume:  108     ISSN:  1742-7843     ISO Abbreviation:  Basic Clin. Pharmacol. Toxicol.     Publication Date:  2011 Jun 
Date Detail:
Created Date:  2011-05-13     Completed Date:  2012-01-09     Revised Date:  2012-01-13    
Medline Journal Info:
Nlm Unique ID:  101208422     Medline TA:  Basic Clin Pharmacol Toxicol     Country:  Denmark    
Other Details:
Languages:  eng     Pagination:  428-35     Citation Subset:  IM    
Copyright Information:
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.
Affiliation:
Department of Pharmacology, School of Medicine, University of Zagreb, Croatia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Aryldialkylphosphatase / blood,  metabolism*
Gemfibrozil / metabolism,  pharmacology*,  toxicity
Heart / drug effects,  physiology
Hydrogen Peroxide / metabolism
Hypolipidemic Agents / metabolism,  pharmacology*,  toxicity
Kidney / drug effects,  enzymology
Lipid Peroxidation / drug effects
Lipid Peroxides / metabolism
Liver / drug effects,  enzymology,  metabolism
Male
Malondialdehyde / metabolism*
Peroxisomes / drug effects
Rats
Rats, Inbred F344
Rats, Wistar
Chemical
Reg. No./Substance:
0/Hypolipidemic Agents; 0/Lipid Peroxides; 25812-30-0/Gemfibrozil; 542-78-9/Malondialdehyde; 7722-84-1/Hydrogen Peroxide; EC 3.1.8.1/Aryldialkylphosphatase
Comments/Corrections
Erratum In:
Basic Clin Pharmacol Toxicol. 2011 Oct;109(4):319
Note: Marija, Macan [corrected to Macan, Marija]; Paško, Konjevoda [corrected to Konjevoda, Paško]; Jasna, Lovrić [corrected to Lovric, Jasna];Marijan, Koprivanac [corrected to Koprivanac, Marijan]; Marta, Kelava [corrected to Kelava, Marta]; Nada, Vrkić [corrected to Vrkic, Nada]; Vlasta, Bradamante [corrected to Bradamante, Vlasta]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Protective Effect of Aminophylline against Cigarette Smoke Extract- Induced Apoptosis in Human Lung ...
Next Document:  MONOCYTE-SUPPRESSING EFFECT OF BEZAFIBRATE BUT NOT OMEGA-3 FATTY ACIDS IN PATIENTS WITH ISOLATED HYP...